Surfactant Dissolution and Water Solubilization in Chlorine-Free Liquified Gas Propellants

References

• Montreal Protocol on Substances That Deplete the Ozone Layer. Liaison Office of the United Nations Environmental Program, New York 1989
   Google Scholar
• Daly J. J., Jr., SanGiovanni M. L. Replacement for CFC propellants: A technical/environmental overview. Spray Tech Marketing 1993; 3: 34–38
   Google Scholar
• Ravishankara A. R., Tumipseed A. A., Jensen N. R., Barone S., Mills M., Howard C. J., Solomon S. Do hydrofluorocarbons destroy stratospheric ozone?. Science 1994; 263: 71–75
   PubMed Web of Science ®Google Scholar
• Dalby R. N., Byron P. R. Metered-dose inhalers containing flammable propellants: perspectives and some safety evaluation procedures. Pharm. Tech. 1991; 15: 54–66
   Google Scholar
• Byron P. R., Miller N. C., Blondino F. E., Visich J. E., Ward G. H. Some aspects of alternative propellant solvency. Respiratory Drug Delivery, P. R. Byron, R. N. Dalby, S. J. Farr. Interpharm Press, Philadelphia, PA 1994; IV: 231–242
   Google Scholar
• Purewal T. S., Greenleaf D. J. Medicinal aerosol formulations. European Patent #0,372,777, 1990
   Google Scholar
• Dalby R. N., Byron P. R. Comparison of output particle size distributions for pressurized aerosols formulated as solutions or suspensions. Pharm. Res. 1988; 5: 36–39
   PubMed Web of Science ®Google Scholar
• Phillips E. M., Byron P. R. Surfactant promoted crystal growth of micronized methylprednisolone in trichloromonofluoromethane. Int. J. Pharm. 1994; 110: 9–19
   Web of Science ®Google Scholar
• Wang Y. C. J., Kowal R. R. Review of excipients and pH's for parenteral products used in the United States. J. Parent. Drug Assoc 1980; 34: 452–462
   PubMedGoogle Scholar
• Evans R. M., Farr S. J., Armstrong N. A., Chatham S. M. Formulation and in vitro evaluation of pressurized inhalation aerosols containing isotropic systems of lecithin and water. Pharm. Res. 1991; 8: 629–635
   PubMed Web of Science ®Google Scholar
• Byron P. R., Patton J. S. Drug delivery via the respiratory tract. J. Aerosol Med. 1994; 7: 49–75
   PubMedGoogle Scholar
• Ross S., Oliver J. P. A new method for the determination of critical micelle concentrations of un-ionized association colloids in aqueous or in non-aqueous solutions. J. Phys. Chem. 1959; 63: 1671–1674
   Web of Science ®Google Scholar
• Ross S., Baldwin V. H., Jr. The interaction between iodine and micelles of amphipathic agents in nonaqueous solutions. J. Colloid Inter. Sci. 1966; 21: 284–292
   Web of Science ®Google Scholar
• Byron P. R. Aerosol formulation, generation, and delivery using metered systems. Respiratory Drug Delivery, P. R. Byron. CRC Press, Boca Raton, FL 1990; 167–205
   Google Scholar
• United States Pharmacopeia and National Formulary. USP Convention, Inc., Rockville, MD 1995; 547, 2259, 2290, 2307, 2308
   Google Scholar
• Fendler J. H. Surfactants in apolar media. Membrane Mimetic Chemistry. Characterizations and Applications of Micelles, Microemulsions, Monolayers, Bilayers, Vesicles, Host-Guest Systems, and Polyions, J. H. Fendler. John Wiley & Sons, New York 1982; 48–77
   Google Scholar
• Byron P. R., Blondino F. E. Metered dose inhaler formulations which include the ozone-friendly propellant HFC 134a and a pharmaceutically acceptable suspending, solubilizing, wetting, emulsifying or lubricating agent. U.S. Patent #5,492,688, 1996
   Google Scholar
• Byron P. R., Blondino F. E. Pharmaceutically acceptable agents for, solubilizing, wetting, emulsifying or lubricating in metered dose inhaler formulations which use HFC-227 propellant. U.S. Patent #5,508,023, 1996
   Google Scholar
• Higuchi T. Solubility. Pharmaceutical Compounding and Dispensing, R. A. Lyman. Lippincott, Philadelphia, PA 1949; 159–190
   Google Scholar
• Boulden M. E. Use of dimethyl ether for reduction of VOC content. Spray Tech. Marketing 1992; 2: 30–36
   Google Scholar
• Bohnenn L. J. M. Recent European developments in DME technology. 1988, Aerosol Age, September, 26-29
   Google Scholar
• Martin A., Swarbrick J., Cammarata A. States of matter and phase equilibria. Physical Pharmacy, 3rd Ed., A. Martin, J. Swarbrick, A. Cammarata. Lea & Febiger, Philadelphia, PA 1983; 62–92
   Google Scholar
• , DuPont. Blends of Dymel® 22/A (40/60) azeotrope and hydrocarbons provide virtually constant pressure over wide range of component concentration, Dymel Aerosol Propellants Information, Technical Bulletin #ATB-10 Wilmington, DE
   Google Scholar
• Evans R. M., Attwood D., Chatham S. M., Farr S. J. A novel strategy for the formulation of medicinal aerosols. J. Aerosol Sci. 1989; 20: 1309–1312
   Web of Science ®Google Scholar
• Luisi P. L., Magid L. J. Solubilization of enzymes and nucleic acids in hydrocarbon micellar solutions. CRC Crit. Rev. Biochem. 1986; 20: 409–474
   PubMed Web of Science ®Google Scholar
• Eastoe J., Young W. K., Robinson B. H., Steytler D. C. Scattering studies of microemulsions in lowdensity alkanes. J. Chem. Soc. Faraday Trans. 1990; 86: 2883–2889
   Google Scholar
• Ross S., Morrison I. D. Emulsions. Colloidal Systems and Interface, S. Ross, I. D. Morrison. John Wiley & Sons, New York, NY 1988; 267–293
   Google Scholar
• Miller N. C. The effects of water in inhalation suspension aerosol formulations. Respiratory Drug Delivery, P. R. Byron. CRC Press, Boca Raton, FL 1990; 249–257
   Google Scholar
• Dalby R. N., Phillips E. M., Byron P. R. Determination of drug solubility in aerosol propellants. Pharm. Res. 1991; 8: 1206–1209
   PubMed Web of Science ®Google Scholar
• Phillips E. M., Byron P. R., Dalby R. N. Axial ratio measurements for early detection of crystal growth in suspension-type metered dose inhalers. Pharm. Res. 1993; 10: 454–456
   PubMed Web of Science ®Google Scholar
• Soine W. H., Blondino F. E., Byron P. R. Chemical stability in pressurized inhalers formulated as solutions. J. Biopharm. Sci. 1992; 3: 41–47
   Google Scholar